High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats

The role of obesity in kidney disease: recent findings and potential mechanisms

(2011) Rigas G. Kalaitzidis et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis

(2011) Yuki Tanaka et al.   KIDNEY INTERNATIONAL

Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men

(2010) Sachiko Tamba et al.   ATHEROSCLEROSIS

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

(2010) T. M. E. Davis et al.   DIABETOLOGIA

Fenofibrate Treatment Enhances Antioxidant Status and Attenuates Endothelial Dysfunction in Streptozotocin-Induced Diabetic Rats

(2010) Murat Olukman et al.   Experimental Diabetes Research

Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta

(2010) Hua Li et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Association of Subcutaneous and Visceral Adiposity With Albuminuria: The Framingham Heart Study

(2010) Meredith C. Foster et al.   Obesity

Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK–eNOS Pathway

(2009) G Deng et al.   INTERNATIONAL JOURNAL OF OBESITY

High Prevalence of Microalbuminuria in the Overweight and Obese Population: Data from a UK Population Screening Programme

(2009) Bisher Kawar et al.   NEPHRON CLINICAL PRACTICE

Microalbuminuria and obesity: impact on cardiovascular disease and mortality

(2008) Klaus Peder Klausen et al.   CLINICAL ENDOCRINOLOGY

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy

(2008) M. Satoh et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION